• Thurs news: Novartis not joining weight loss race. Pharma marketing and climate change. Roche flu treatment trial. Cercle’s fund raise for women’s health. ICER looks at GSK COPD drugs. See more on our front page

FDA staff raises concerns over data from J&J, Bristol's CAR-T therapies

Quote
cafead

cafead

Administrator
Staff member
  • cafead   Mar 13, 2024 at 11:02: AM
via The U.S. Food and Drug Administration's staff on Wednesday raised concerns that it was unclear if Johnson & Johnson and Bristol Myers Squibb's cancer cell therapies would benefit blood cancer patients when given as early treatments.

article source
 

<



Similar threads

cafead
FDA staff raises concerns on Geron&#039;s blood disorder drug
Replies
0
Views
91
Pharma/Biotech Companies - In the News
cafead
cafead
cafead
FDA staff raises no new concerns about Abbott&#039;s heart device
Replies
0
Views
118
Pharma/Biotech Companies - In the News
cafead
cafead
cafead
FDA staff raises efficacy doubts on GSK&#039;s lung disease treatment
Replies
0
Views
147
Pharma/Biotech Companies - In the News
cafead
cafead
cafead
US FDA staff questions confirmatory trial data for Intercept&#039;s liver disease drug
Replies
0
Views
32
Pharma/Biotech Companies - In the News
cafead
cafead
cafead
FDA staff raise no major concerns about Eli Lilly Alzheimer&#039;s drug
Replies
0
Views
18
Pharma/Biotech Companies - In the News
cafead
cafead
Top Bottom
Back
Quote